Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,630 total articles

Duluth Holdings Inc. Announces Second Quarter 2026 Financial Results

Duluth Holdings Inc. Announces Second Quarter 2026 Financial Results

Duluth Holdings Inc. announced robust financial results for its second quarter ended August 2, 2026, delivering a net income of $18.4 million, a marked increase from $1.3 million in the prior year's quarter. This improvement was largely driven by gross margin expansion aided by $16.3 million in tariff refunds and effective inventory management with…

Amid AI Boom, Verisk Launches New View of U.S. Data Center Exposure, Helping Insurers Assess Growing Concentrations of Risk

Amid AI Boom, Verisk Launches New View of U.S. Data Center Exposure, Helping Insurers Assess Growing Concentrations of Risk

Verisk has introduced a comprehensive U.S. Data Center Exposure Database designed to provide insurers, reinsurers, and brokers with detailed information about data center locations and characteristics, addressing the rapidly increasing concentration of risk due to AI-driven digital infrastructure expansion. This tool aims to improve underwriting, e…

Reborn Coffee Receives Nasdaq Notification Regarding Late 10-Q Filing and Continued Listing Requirements

Reborn Coffee Receives Nasdaq Notification Regarding Late 10-Q Filing and Continued Listing Requirements

Reborn Coffee Inc., a specialty coffee retailer listed on Nasdaq under ticker REBN, received a notice for failing to file its 10-Q report on time, placing it out of compliance with Nasdaq's listing rules. The company has 60 days to submit a plan to regain compliance and may be granted up to 180 additional days to file. There is no assurance the com…

LEQEMBI® (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China

LEQEMBI® (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China

Biogen and Eisai announced that China's National Medical Products Administration has approved the subcutaneous autoinjector formulation of LEQEMBI (lecanemab) for treating mild cognitive impairment and mild Alzheimer's dementia. This allows once-weekly at-home injections, offering a more convenient alternative to intravenous administration, and is …

Ming Shing Group Holdings Limited Announces Closing of the Acquisition of Meals Through Seasons Limited and Issuance of Consideration Shares and Unsecured Convertible Promissory Notes

Ming Shing Group Holdings Limited Announces Closing of the Acquisition of Meals Through Seasons Limited and Issuance of Consideration Shares and Unsecured Convertible Promissory Notes

Ming Shing Group Holdings Limited announced the closing of its acquisition of Meals Through Seasons Limited for USD 510 million, paid entirely in securities including 150 million Class A shares and USD 360 million in unsecured convertible promissory notes. The notes are structured with annual performance tranches tied to profit targets and have no …

Diversified Announces Accretive Acquisition of Birch

Diversified Announces Accretive Acquisition of Birch

Diversified Energy Company (NYSE: DEC) has entered into definitive agreements to acquire Birch Permian Holdings for approximately $1.8 billion, marking its largest acquisition ever. The deal enhances Diversified's position as a major operator in the Permian Basin by increasing production by about 35% and adjusted EBITDA by approximately 55%. The ac…

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

Revolution Medicines announced that the New England Journal of Medicine has published Phase 1/2 clinical trial data on their drug RASONQUE (daraxonrasib) in treating RAS mutant non-small cell lung cancer (NSCLC). The study showed promising objective response and disease control rates with a manageable safety profile. The data supports the ongoing P…

BioRestorative Therapies Announces Reverse Stock Split

BioRestorative Therapies Announces Reverse Stock Split

BioRestorative Therapies, Inc. announced a 1-for-20 reverse stock split effective September 7, 2026, aiming to regain compliance with Nasdaq's $1.00 minimum bid price listing rule. The stock will begin trading on a reverse-split basis on September 8, 2026, maintaining current shareholder ownership percentages. The company is a clinical-stage regene…

Capital Southwest Increases Corporate Credit Facility to $595 million and Extends Maturity to September 2031

Capital Southwest Increases Corporate Credit Facility to $595 million and Extends Maturity to September 2031

Capital Southwest Corporation announced an amendment to its senior secured corporate credit facility, increasing borrowing capacity from $510 million to $595 million with an option to expand to $1 billion. The amendment reduces interest margins, lowers unused commitment fees, removes the SOFR adjustment, and extends the maturity to September 2031. …

Archimedes Tech SPAC Partners II Co. Announces Filing of Third Amendment to Registration Statement on Form S-4 with the SEC

Archimedes Tech SPAC Partners II Co. Announces Filing of Third Amendment to Registration Statement on Form S-4 with the SEC

Archimedes Tech SPAC Partners II Co. (ATII), a Nasdaq-listed special purpose acquisition company (SPAC), announced the filing of the third amendment to its registration statement on Form S-4 with the SEC related to its proposed business combination with Forge Nano, Inc. Forge Nano specializes in advanced atomic layer deposition technology critical …

RoboStrategy, Inc. Updates Net Asset Value as of August 31, 2026

RoboStrategy, Inc. Updates Net Asset Value as of August 31, 2026

RoboStrategy, Inc., a Nasdaq-listed closed-end fund focused on robotics and physical AI private companies, announced its net asset value (NAV) per share rose to $11.35 as of August 31, 2026, representing a 0.27% increase month-over-month. The fund invests in leading innovators in robotics and autonomous systems to bridge public market access to pri…

Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares Third Quarter Common Stock Distribution of $0.1503 Per Share

Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares Third Quarter Common Stock Distribution of $0.1503 Per Share

Sprott Focus Trust, Inc. has declared a quarterly distribution of $0.1503 per share on its Common Stock to be paid on September 29, 2026. The distribution follows the Fund's policy targeting an annualized 6% payout based on the rolling average NAV. The distribution can be taken in cash or reinvested in additional shares, and the Fund reported stron…

Fort Technology Grants Restricted Share Units

Fort Technology Grants Restricted Share Units

Fort Technology Inc. has granted 102,857 restricted share units (RSUs) under its approved Omnibus Equity Incentive Plan, which includes allocations to an officer and consultants. The RSUs vest over a scheduled timeline and are subject to TSX Venture Exchange policies. Fort Technology, specializing in consumer products for pest control and remedial …

Byrna Appoints Matt McBrady to Board of Directors

Byrna Appoints Matt McBrady to Board of Directors

Byrna Technologies Inc., a Nasdaq-listed personal defense technology company, has appointed Matthew McBrady, Ph.D., to its Board of Directors. McBrady brings extensive experience from his tenure at Axon Enterprise and various leadership roles in finance and investment. The appointment aligns with Byrna's efforts to refresh its board and leverage Mc…

Costco Wholesale Corporation Reports August Sales Results

Costco Wholesale Corporation Reports August Sales Results

Costco Wholesale Corporation announced a 9.9% increase in net sales for August 2026, reaching $23.7 billion, and an 11.3% rise for the fourth quarter, totaling $93.9 billion. For the full fiscal year ending August 30, 2026, net sales increased by 10.2% to $297.3 billion. Comparable sales growth was robust across the U.S., Canada, and international …